Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >API>Urinary System Drugs>Diuretics Drugs>Azosemide
Azosemide
  • Azosemide

Azosemide NEW

Price $41 $58 $89
Package 25mg 50mg 100mg
Supply Ability: 10g
Update Time: 2026-06-02

Product Details

Product Name: Azosemide CAS No.: 27589-33-9
Purity: 99.84% Supply Ability: 10g
Release date: 2026/06/02

Product Introduction

Bioactivity

NameAzosemide
DescriptionAzosemide is a potent NKCC1 inhibitor (IC50s: 0.246 µM and 0.197 µM for hNKCC1A and NKCC1B).
In vitroAzosemide inhibits the human sodium-potassium-chloride cotransporter variants hNKCC1B and hNKCC1A [1].
In vivoAzosemide shows a shorter terminal half-life (50.9% decrease) and MRT (64.1% decrease), smaller AUC (81.9% decrease), faster CL (454% increase), CLNR (307% increase) and CLR (853% increase) for NARs [2].
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature.
Solubility InformationDMSO : 250 mg/mL (674.15 mM), Sonication is recommended.
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 10 mg/mL (26.97 mM), Solution.
10% DMSO+90% Saline : < 10 mg/mL (26.97 mM), Lower concentrations may be soluble, but exact solubility limit is unknown.
Keywordssulfonamide | NKCC1B | NKCC1 | NKCC | NaKClcotransporter | Na-K-Cl cotransporter | NaKCl cotransporter | loop | Inhibitor | inhibit | hNKCC1A | diuretic | Azosemide
Inhibitors RelatedFurosemide-D5 | Bumetanide (Standard) | Bumetanide sodium | KCC2 potentiators-1 | Sodium dichloroacetate | Piretanide | Bumetanide-D5 | Furosemide | Furosemide sodium | ZT-1a | Bumetanide | Torsemide
Related Compound LibrariesBioactive Compound Library | Membrane Protein-targeted Compound Library | ReFRAME Related Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Anti-Cardiovascular Disease Compound Library | Anti-Cancer Approved Drug Library | Bioactive Compounds Library Max | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Anti-Hypertension Compound Library

Company Profile Introduction

Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers. TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.

You may like

Recommended supplier

Product name Price   Suppliers Update time
$41.00
VIP4Y
TargetMol Chemicals Inc.
2026-06-02
$1.00
VIP5Y
Hebei Dangtong Import and export Co LTD
2026-02-25
VIP2Y
Shaanxi Dideu New Materials Co. Ltd
2025-12-01
$1.10
VIP6Y
Dideu Industries Group Limited
2025-11-18
$50.00
Hebei Yanxi Chemical Co., Ltd.
2025-06-20
$100.00
Weijer International Trade (Hebei) Co., Ltd
2023-08-16
$100.00
Henan Bao Enluo International TradeCo.,LTD
2023-06-17
$25.00
XINGTAI XINGJIU NEW MATERIAL TECHNOLOGY CO., LTD
2023-03-27
$1.00
Anhui Rencheng Technology Co., Ltd
2023-01-12
$100.00
Shijiazhuang Suking Biotechnology Co .,Ltd.
2022-12-15

TargetMol Chemicals Inc.

6YR United StatesUnited States
  • Since: 2011-01-07
  • Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY